Business Wire

SOSAFE

29.5.2024 13:13:30 CEST | Business Wire | Press release

Share
SoSafe Announces New Executive Advisors as Company Expands Category and Product Leadership

SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed four new Executive Advisors. The advisors, comprised of industry experts and technology investors, will provide advice and strategic counsel to the SoSafe leadership team on its ambitious plans to expand their category and product leadership.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240529386435/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

New hires Ilona Simpson, Carsten Thoma, Christian Karam, Sean Catlett (Photo: Business Wire)

With Forrester predicting that 90% of data breaches in 2024 will involve the human element, reducing human risk is what organisations need to prioritize for business continuity. SoSafe offers a technology-driven solution based on psychology and human-centric design. While SoSafe is committed to empowering digital self-defence around the world, the company is currently leading the category evolution from security awareness and training to human risk management. The Executive Advisors will support this transformative process from both an industry and organisational perspective to increase the company's speed to scale.

The following Executive Advisors will join:

Sean Catlett: Sean is the Chief Information Security and Trust Officer at Bumble. He also served as the Chief Security Officer at Slack, and as Chief Information Security Officer at Reddit and is an advisor to Balance Theory and Hampton North.

"It is clear that cybercriminals are effective at focusing on the human layer of security. AI-powered tools offer them solutions that scale attack success rates, intensifying cyber threats, and I believe the full potential is yet to be seen. We need comprehensive and effective solutions that counter these rising threats by sustainably empowering a strong security culture and reducing human risk - and SoSafe delivers just that in a new and innovative way", states Sean Catlett.

Christian Karam: Christian is an investor and senior advisor on technology investments, previously serving as the Deputy Group Chief Information Security Officer at UBS and the Head of Research & Innovation at INTERPOL.

“Cybercriminals continue to innovate rapidly, outpacing many organisations’ ability to keep up. Mere compliance training videos are no longer enough to overcome this challenge. We must rethink security awareness by building effective and robust security cultures that embrace continuous learning and treat mistakes as key drivers of resilience. SoSafe is leading this transformation towards holistic, people-centric human risk management, and I look forward to contributing to this journey”, says Christian Karam.

Ilona Simpson: Ilona is a trained psychologist and a long-standing CIO across a range of industries and companies, having worked at Netskope, adidas, EON, Aston Martin, DHL, and Porsche.

"We've made a lot of progress over the last few years in terms of the attention that senior management and boards are giving to the human layer of cybersecurity. For CIOs, the human factor and reducing human risk is top of mind. Now, they need effective and simple solutions to help them reduce human risk in a sustainable way”, states Ilona Simpson.

Carsten Thoma: Carsten is the President of Celonis. He has co-founded and scaled Hybris, sold to SAP and became President of SAP CX and member of the Global Executive Team. He serves as an advisor to La Famiglia/General Catalyst, and has been a long-standing investor and entrepreneur.

"SoSafe has the most promising foundation a young company can have: They are solving one of the most important business problems of our time in a fundamentally different way than their competitors. It's my ambition to help them succeed and, together with SoSafe's leadership team, build a global champion from Europe”, states Carsten Thoma.

“We are very honoured that some of the best minds in business and technology have agreed to serve as critical advisors to SoSafe. At this pivotal time in our development, their expertise will enable us to grow even faster, smarter, and more focused. I know I speak for the rest of the executive team when I say that we will value their experienced counsel as we look to accelerate our growth as a company”, states Dr Niklas Hellemann, Psychologist and CEO at SoSafe.

About SoSafe

SoSafe, founded by a team of behavioural scientists and technology experts, is the largest security awareness and human risk management vendor based in Europe. SoSafe is empowering over 4700 customers worldwide to effectively mitigate cyber risk. With a unique human-centric approach grounded in behavioural science, SoSafe enhances secure behaviour across organizations, making it intuitive and second nature. The platform is designed to strengthen digital self-defence by creating robust security cultures that actively involve employees in mitigating human risks. By leveraging psychology and advanced technology and AI, it enables security professionals to effectively identify, prioritize, manage, and ultimately reduce their human risk. The SoSafe team now consists of more than 450 employees in seven locations: Cologne (headquarters), Amsterdam, Berlin, London, Paris, Lisbon, and Munich.

Website: www.sosafe-awareness.com/
LinkedIn: www.linkedin.com/company/sosafe-cyber-security/mycompany/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529386435/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From AI to Autonomous Networks: Mobileum Spark Highlights the Next Frontier of Telecom Intelligence15.10.2026 09:00:00 CEST | Press release

Industry leaders get together to explore how trusted AI, Agentic Intelligence and automation are transforming risk management, accelerating autonomous network operations and unlocking new opportunities for value creation Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics and network solutions, brought together telecom operators and industry leaders during its Mobileum Spark events series in Lisbon (Portugal) and Frankfurt (Germany), to explore how Artificial Intelligence (AI), Agentic AI and automation are transforming network operations and accelerating the evolution toward autonomous networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015172815/en/ Telecom operators, industry leaders, and Mobileum experts at Mobileum Spark 2026. Focused on Risk Management & Fraud Prevention and Network Testing & Assurance, the events featured customer-led discussions, expert insights, and real-world use case

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release

Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release

Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release

Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release

− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye